No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Cardiac magnetic field map topology quantified by Kullback-Leibler entropy identifies patients with hypertrophic cardiomyopathy
1.C. E. Seidman and J. G. Seidman, “Molecular genetic studies of familial hypertrophic cardiomyopathy,” Basic Res. Cardiol. 93, 13–16 (1998).
2.L. Thierfelder, H. Watkins, C. MacRae, R. Lamas, W. McKenna, H. P. Vosberg, J. G. Seidman, and C. E. Seidman, “Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere,” Cell 77, 701–712 (1994).
3.B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer, III, P. Spirito, F. J. Ten Cate, and E. D. Wigle, “American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines,” J. Am. Coll. Cardiol. 42, 1687–1713 (2003).
4.T. Tsoutsman, L. Lam, and C. Semsarian, “Genes calcium and modifying factors in hypertrophic cardiomyopathy,” Clin. Exp. Pharmacol. Physiol. 33, 139–145 (2006).
5.B. J. Maron, H. Niimura, S. A. Casey, M. K. Soper, G. B. Wright, J. G. Seidman, and C. E. Seidman, “Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations,” J. Am. Coll. Cardiol. 38, 315–321 (2001).
6.C. Y. Ho and C. E. Seidman, “A contemporary approach to hypertrophic cardiomyopathy,” Circulation 113, e858–e862 (2006).
7.P. Spirito, F. Chiarella, L. Carratino, M. Z. Berisso, P. Bellotti, and C. Vecchio, “Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population,” N. Engl. J. Med. 320, 749–755 (1989).
8.P. Spirito and C. Autore, “Management of hypertrophic cardiomyopathy,” BMJ 332, 1251–1255 (2006).
9.P. Caso, A. D’Andrea, I. Caso, S. Severino, P. Calabro, F. Allocca, N. Mininni, and R. Calabro, “The athlete’s heart and hypertrophic cardiomyopathy: two conditions which may be misdiagnosed and coexistent. Which parameters should be analysed to distinguish one disease from the other ?” J Cardiovasc Med (Hagerstown) 7, 257–266 (2006).
10.B. J. Maron, “Q waves in hypertrophic cardiomyopathy: A reassessment,” J. Am. Coll. Cardiol. 16, 375–376 (1990).
11.K. Nakai, H. Izumoto, K. Kawazoe, J. Tsuboi, Y. Fukuhiro, T. Oka, K. Yoshioka, M. Shozushima, M. Itoh, A. Suwabe, and M. Yoshizawa, “Three-dimensional recovery time dispersion map by 64-channel magnetocardiography may demonstrate the location of a myocardial injury and heterogeneity of repolarization,” Int. J. Card. Imaging 22, 573–580 (2006).
12.D. Brisinda, A. M. Meloni, and R. Fenici, “Contact less magnetocardiographic study of ventricular repolarization in intact Wistar rats: evidence of gender-related differences,” Basic Res. Cardiol. 99, 193–203 (2004).
13.S. Comani, S. Gallina, A. Lagatta, M. Orlandi, G. Morana, S. De Luzio, D. Brisinda, R. De Caterina, R. Fenici, and G. L. Romani, “Concentric remodeling detection by magnetocardiography in patients with recent onset arterial hypertension,” Pacing Clin. Electrophysiol. 27, 709–718 (2004).
14.M. Karvonen, L. Oikarinen, P. Takala, M. Kaartinen, J. Rossinen, H. Hanninen, J. Montonen, J. Nenonen, M. Makijarvi, P. Keto, L. Toivonen, M. S. Nieminen, and T. Katila, “Magnetocardiographic indices of left ventricular hypertrophy,” J. Hypertens. 20, 2285–2292 (2002).
15.L. Fananapazir, C. M. Tracy, M. B. Leon, J. B. Winkler, R. O. Cannon, 3rd, R. O. Bonow, B. J. Maron, and S. E. Epstein, “Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients,” Circulation 80, 1259–1268 (1989).
16.G. Limongelli, G. Pacileo, F. Cerrato, M. Verrengia, A. Di Simone, S. Severino, B. Sarubbi, and R. Calabro, “Myocardial ultrasound tissue characterization in patients with hypertrophic cardiomyopathy: noninvasive evidence of electrical and textural substrate for ventricular arrhythmias,” J. Am. Soc. Echocardiogr 16, 803–807 (2003).
17.R. Fenici, D. Brisinda, J. Nenonen, and P. Fenici, “Phantom validation of multichannel magnetocardiography source localization,” Pacing Clin. Electrophysiol. 26, 426–430 (2003).
18.S. Kullback and R. A. Leibler, “On information and sufficiency,” Ann. Math. Stat. 22, 79–86 (1951).
19.I. Barrodale, D. Skea, M. Berkley, R. Kuwahara, and R. Poeckert, “Warping digital images using thin plate splines,” Pattern Recogn. 26, 375–376 (1993).
20.F. Kornreich, T. J. Montague, and P. M. Rautaharju, “Identification of first acute Q wave and non-Q wave myocardial infarction by multivariate analysis of body surface potential maps,” Circulation 84, 2442–2453 (1991).
21.P. Van Leeuwen, B. Hailer, S. Lange, and D. H. Gronemeyer, “Identification of patients with coronary artery disease using magnetocardiographic signal analysis,” Biomed. Tech. 51, 83–88 (2006).
22.H. Hanninen, M. Holmstrom, P. Vesterinen, M. Karvonen, H. Vaananen, L. Oikarinen, M. Makijarvi, J. Nenonen, K. Lauerma, T. Katila, and L. Toivonen, “Magnetocardiographic assessment of healed myocardial infarction,” Ann Noninvasive Electrocardiol 11, 211–221 (2006).
23.W. Gersch, F. Martinelli, J. Yonemoto, M. D. Low, and J. A. Mc Ewan, “Automatic classification of electroencephalograms: Kullback-Leibler nearest neighbor rules,” Science 205, 193–195 (1979).
24.N. Wessel, A. Voss, J. Kurths, A. Schirdewan, K. Hnatkova, and M. Malik, “Evaluation of renormalised entropy for risk stratification using heart rate variability data,” Med. Biol. Eng. Comput. 38, 680–685 (2000).
25.D. Pokrajac, V. Megalooikonomou, A. Lazarevic, D. Kontos, and Z. Obradovic, “Applying spatial distribution analysis techniques to classification of 3D medical images,” Artif. Intell. Med. 33, 261–280 (2005).
26.A. M. Varnava, P. M. Elliott, N. Mahon, M. J. Davies, and W. J. McKenna, “Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy,” Am. J. Cardiol. 88, 275–279 (2001).
27.P. Assayag, F. Carre, B. Chevalier, C. Delcayre, P. Mansier, and B. Swynghedauw, “Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis,” Cardiovasc. Res. 34, 439–444 (1997).
28.R. C. Saumarez, A. J. Camm, A. Panagos, J. S. Gill, J. T. Stewart, M. A. de Belder, I. A. Simpson, and W. J. McKenna, “Ventricular fibrillation in hypertrophic cardiomyopathyis associated with increased fractionation of paced right ventricular electrograms,” Circulation 86, 467–474 (1992).
29.C. A. Dumont, L. Monserrat, R. Soler, E. Rodriguez, X. Fernandez, J. Peteiro, A. Bouzas, B. Bouzas, and A. Castro-Beiras, “Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance,” Eur. Heart J. 27, 1725–1731 (2006).
30.R. Lemery, A. Kleinebenne, P. Nihoyannopoulos, V. Aber, F. Alfonso, and W. J. McKenna, “Q waves in hypertrophic cardiomyopathy in relation to the distribution, severity of right and left ventricular hypertrophy,” J. Am. Coll. Cardiol. 16, 368–374 (1990).
31.R. J. Kim and R. M. Judd, “Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: In vivo imaging of the pathological substrate for premature cardiac death?” J. Am. Coll. Cardiol. 41, 1568–1572 (2003).
32.C. Ramanathan, P. Jia, R. Ghanem, K. Ryu, and Y. Rudy, “Activation and repolarization of the normal human heart under complete physiological conditions,” Proc. Natl. Acad. Sci. U.S.A. 103, 6309–6314 (2006).
33.L. Choudhury, H. Mahrholdt, A. Wagner, K. M. Choi, M. D. Elliott, F. J. Klocke, R. O. Bonow, R. M. Judd, and R. J. Kim, “Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy,” J. Am. Coll. Cardiol. 40, 2156–2164 (2002).
34.B. Schumacher, F. H. Gietzen, H. Neuser, J. Schummelfeder, M. Schneider, S. Kerber, R. Schimpf, C. Wolpert, and M. Borggrefe, “Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms,” Circulation 112, 2096–3101 (2005).
35.E. R. Behr, P. Elliott, and W. J. McKenna, “Role of invasive EP testing in the evaluation and management of hypertrophic cardiomyopathy,” Card Electrophysiol Rev 6, 482–486 (2002).
36.G. Barletta, C. Lazzeri, F. Franchi, R. Del Bene, and A. Michelucci, “Hypertrophic cardiomyopathy: Electrical abnormalities detected by the extended-length ECG and the irrelation to syncope,” Int. J. Cardiol. 97, 43–48 (2004).
37.B. J. Maron, “Hypertrophic cardiomyopathy,” Curr. Probl Cardiol. 18, 639–704 (1993).
38.C. Basso, G. Thiene, D. Corrado, G. Buja, P. Melacini, and A. Nava, “Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia,” Hum. Pathol. 31, 988–998 (2000).
39.M. Burghoff, J. Nenonen, L. Trahms, and T. Katila, “Conversion of magnetocardiographic recordings between two different multichannel SQUID devices,” IEEE Trans. Biomed. Eng. 47, 869–875 (2000).
40.B. J. Maron, J. G. Seidman, and C. E. Seidman, “Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy,” J. Am. Coll. Cardiol. 44, 2125–2132 (2004).
41.P. Charron and M. Komajda, “Molecular genetics in hypertrophic cardiomyopathy: Towards individualized management of the disease,” Expert Rev Mol Diagn 6, 65–78 (2006).
Article metrics loading...
Full text loading...
Most read this month